High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer

NCT01646034 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: carboplatin, thiotepa, and cyclophosphamide
DRUG: chemotherapy (docetaxel, doxorubicin, cyclofosfamide, carboplatin, paclitaxel, gemcitabine)

Sponsor

The Netherlands Cancer Institute